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962severe transprosthetic regurgitation (Figure 1G). The
THV leaﬂets appeared torn. The patient subsequently
underwent successful repeat transfemoral valve-in-
valve TAVR with a second 26-mm SAPIEN THV placed
slightly superior to the ﬁrst THV (Figure 1H, arrow
[before deployment]). There was moderate peri-
prosthetic residual regurgitation despite post-THV
deployment balloon dilatation, but native leaﬂet
overhang was eliminated. At 1-year follow-up after the
valve-in-valve TAVR, the THV mean gradient was 14
mm Hg, and the degree of periprosthetic regurgitation
was mild. In retrospect, the aortic valve annulus
diameter according to computed tomography scan
measured 28 mm, suggesting that the 26-mm THV was
undersized.
Mechanisms responsible for downward THV
migration can include native leaﬂet overhang post-
deployment, exerting downward force on the THV
(1,2) or limited anchoring of the THV from low
deployment in a relatively large and nonseverely
calciﬁed annulus (1) or from deployment of a
THV that is too small for the native aortic valve
annulus. Although rare, delayed THV migration
should be suspected when there is a worsening of
the patient’s clinical status or unfavorable THV he-
modynamic proﬁle (increasing mean gradient or
worsening regurgitation) on follow-up echocardio-
graphic examination.Vuyisile T. Nkomo, MD, MPH*
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Coll Cardiol Intv 2012;5:72–9.LA Emptying Fraction Improves Diagnosis
of Paroxysmal AF After Cryptogenic Ischemic
Stroke: Results From the SURPRISE StudyIn 25% of patients with ischemic stroke, no etiologic
factor is identiﬁed: so-called cryptogenic strokes (CS)
(1). Asymptomatic paroxysmal atrial ﬁbrillation (PAF)
is often suspected to be the cause of stroke in these
patients.
Echocardiographic estimates of left atrial (LA)
function, such as the left atrial emptying fraction
(LAEF), can easily be determined by echocardiogra-
phy and could potentially be a surrogate marker for
already present PAF (2).
The aim of this study was to establish if echocar-
diographic investigation of the LA function would
identify patients with subsequent documentation of
PAF following a CS.
A total of 58 patients with CS were included in the
SURPRISE (Stroke Prior to Diagnosis of Atrial Fibrilla-
tion Using Longterm Observation with Implantable
Cardiac Monitoring Apparatus Reveal) study (clinical
trial number NCT01498146) and underwent conven-
tional 2-dimensional echocardiography a median of
42 days (interquartile range [IQR]: 14 to 134 days) after
the stroke as part of the clinical work-up to identify if
the heart was the source of the ischemic stroke. All
patients had an insertable cardiac monitor implanted
within a time interval after their stroke as per the
current practice recommendations (median 69 days,
IQR: 42 to 127 days). Left atrial volumes (LAV)
were estimated by the biplane area-length method in
the apical 4- and 2-chamber views. The maximal LAV
was measured during left ventricular (LV) end-systole
and minimal LAV during LV end-diastole. The LAEF
was calculated as: (maximal LAV  minimal LAV)/
(maximal LAV). During the course of follow-up (me-
dian 20months, IQR: 11 to 29months) 13 (22%) patients
were diagnosed with PAF. Follow-up was 100%. Atrial
ﬁbrillation was diagnosed a median of 59 days (IQR: 8
to 109 days) after implantation of the insertable car-
diac monitor. No patient experienced any symptoms
in conjunction with the diagnosis of atrial ﬁbrillation.
Patients subsequently diagnosed with PAF were
signiﬁcantly older (65  8 years vs. 51  12 years, p <
0.001) and had signiﬁcantly higher mean CHADS2
(Congestive heart failure, Hypertension, Age $75
years, Diabetes mellitus, Stroke) score (2.9  1.1 vs.
2.4  0.6, p ¼ 0.022) than patients without PAF. Other
than age and CHADS2 score, no baseline characteristic
(sex, hypertension, diabetes, cholesterol, blood
sugar, or body mass index) was associated with PAF.
No patient was diagnosed with an evident
cardioembolic source as a consequence of the
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963echocardiographic examination. None of the con-
ventional echocardiographic parameters (LV ejection
fraction, LV volumes, LV mass index, E/A ratio,
deceleration time, e0, a0, LA volume index, LA vol-
ume index/a0, tricuspid annular plane systolic
excursion, and grade of diastolic dysfunction) were
signiﬁcant predictors of PAF. However, the LAEF was
signiﬁcantly reduced (37  17% vs. 47  11%, p ¼
0.016) in patients subsequently diagnosed with PAF.
The risk of subsequently being diagnosed with PAF
increased with decreasing tertile of the LAEF
(Figure 1), and was approximately 10 higher for
patients in the ﬁrst tertile (with an LAEF #41%)
compared with patients in the third tertile (with an
LAEF >50%) (hazard ratio: 9.6; 95% conﬁdence in-
terval: 1.2 to 77.3; p ¼ 0.033).
Age <60 years and an LAEF >50% individually
predicted the absence of PAF with 94% and 95% ac-
curacy, respectively. Furthermore, an age $60 years
and an LAEF #50% correctly identiﬁed 85% and 92%
of the PAF patients, respectively.
Using joint criteria by combining both cutoff values,
the diagnostic utility was improved. If the patient was
<60 years of age and had an LAEF >50%, the patient
had no risk of PAF, corresponding to a negative pre-
dictive value of 100%. Furthermore, when using $60
years of age and/or an LAEF #50% as warning signals
for the presence of PAF, no patient subsequently
diagnosed with PAF would have been misclassiﬁed,
corresponding to a sensitivity of 100%. In addition, if a
patient was $60 years of age and had an LAEF <50%,
the risk of suffering from PAF was 59%, corresponding
to a positive predictive value of 59%.FIGURE 1 LAEF and the Risk of PAF
Cumulative hazard curves depicting the cumulative risk of
paroxysmal atrial ﬁbrillation (PAF) for patients stratiﬁed into
tertiles of the left atrial emptying fraction (LAEF) (1. tertile
#41%; 2. tertile >41% to #50%; 3. tertile >50).This is the ﬁrst study, using long-term rhythm
monitoring, to demonstrate that a simple echocar-
diographic assessment of the left atrium function
contributes signiﬁcantly to risk stratiﬁcation for PAF
in patients with CS.
We found that a decrease in the LAEF was associ-
ated with an increased risk of PAF (Figure 1).
Furthermore, using joint criteria by combining both
cutoff values of age and LAEF, the diagnostic accu-
racy was increased to 100% for excluding PAF as the
causal reason for the cryptogenic ischemic stroke.
However, these results are from a relatively small
sample size, and unless they are repeated in larger
cohorts, the results cannot be extrapolated to the
entire cohort of cryptogenic stroke patients.Tor Biering-Sørensen, MD*
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